Methyl 5-oxopentanoate

Catalog No.: 
ACMGYR290
CAS No.: 
6026-86-4
Molecular Formula: 
C6H10O3
Molecular Weight: 
130.14
Methyl 5-oxopentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$63.00In stockInquiry
1g97%$173.00In stockInquiry
5g97%$605.00In stockInquiry
10g97%$968.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-oxopentanoate
IUPAC Namemethyl 5-oxopentanoate
MDL No.MFCD09833062
Molecular FormulaC6H10O3
Molecular Weight130.14
SMILESO=C(OC)CCCC=O
InChI KeyYBTZROCKNUIONO-UHFFFAOYSA-N
SynonymPentanoic acid, 5-oxo-, methyl ester;methyl 5-oxopentanoate;Methyl 5-oxovalerate;methyl 4-formyl butyrate
CAS No.6026-86-4
PubChem CID554053

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H227-H315-H319-H335
Precautionary Statement(s)
P210-P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACMGYR290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBVXD361 route compound structure diagram
    ACBVXD36114273-92-8In Stock
  2. Then
  3. ACMGYR290 route product structure diagram
    ACMGYR2906026-86-4In Stock
Inquiry

2. ACMGYR290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBVXD361 route compound structure diagram
    ACBVXD36114273-92-8In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACMGYR290 route product structure diagram
    ACMGYR2906026-86-4In Stock
Inquiry

3. ACMGYR290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGYR290 route product structure diagram
    ACMGYR2906026-86-4In Stock
Inquiry

Comments (0)